FDA Releases Final Guidance on Postmarket Management of Cybersecurity in Medical Devices

At the close of 2016, the U.S. Food and Drug Administration released its final guidance on Postmarket Management of Cybersecurity in Medical Devices. The final guidance is an update of the draft guidance issued in January, 2016, and emphasizes the need for device manufacturers to build in cybersecurity controls during device design and development, and for continuous monitoring and addressing of cybersecurity concerns once the device is on the market. [1/5/16]

Search